Vaccines in Italy: supplies and administrations. Here is the updated data

18 March 20213 years ago babelfish

Vaccines in Italy: supplies and administrations. What emerges from the updated report of the Gimbe Foundation

Of the doses scheduled for the first quarter of 2021, 8,597,500 doses were delivered to the Regions as of March 17, just over half of those scheduled.

As of March 17, 2,145,434 million people (3.6% of the population) completed the vaccination cycle with the second dose, with marked regional differences: from 2.71% in Calabria to 5.12% in Valle D'Aosta.

These are some of the aspects that emerge from the most updated report of the Gimbe Foundation on the pandemic and the vaccination campaign in Italy.

+++

Here is the full report dated March 18, 2021.

The independent monitoring of the Gimbe Foundation detects in the week 10-16 March 2021, compared to the previous one, a further increase in new cases (157,677 vs 145,659) (figure 1) and deaths (2,522 vs 2,191) (figure 2). Currently positive cases continue to rise (536,115 vs 478,883), people in home isolation (506,761 vs 453,734), hospitalizations with symptoms (26,098 vs 22,393) and intensive care (3,256 vs 2,756) (figure 3). In detail, compared to the previous week, the following changes were recorded:

Deaths: 2,522 (+ 15.1%)
Intensive care: +500 (+ 18.1%)
Hospitalized with symptoms: +3,705 (+ 16.5%)
Home isolation: +53,027 (11.7%)
New cases: 157,677 (+ 8.3%)
Currently positive cases: +57.232 (+ 12%)

"The further increase in new cases – says Nino Cartabellotta, President of the Gimbe Foundation – has determined in the last week the net expansion of the basin of currently positive cases, which has increased by over 57 thousand units". Compared to the previous week, the currently positive cases per 100,000 inhabitants are growing in 16 Regions and in 15 there is a percentage increase in new cases (table).

The increase in currently positive cases is reflected in the curves relating to hospital services: the occupation of medical area beds by Covid patients exceeds the alert threshold in 9 regions (> 40%). Even in intensive care, whose national saturation rate exceeds the critical threshold at 36%, employment by Covid patients exceeds 30% in 13 Regions: in particular, in 5 Regions (Tuscany, Abruzzo, Friuli-Venezia Giulia, Piedmont, Molise) is ≥40% and in other 5 it is ≥50% (Emilia Romagna, Lombardy, Umbria, Marche, Autonomous Province of Trento) (figure 5). "Hospital overload – comments Renata Gili, Head of Research on Health Services of the Gimbe Foundation – in addition to making the assistance of Covid patients more complex, increases the stress of hospital staff and services and requires postponing surgery and other non-urgent services for non-Covid patients ".

"What is worrying – explains Marco Mosti, Operations Director of the Gimbe Foundation – is also the growing trend of new daily admissions to intensive care: in 4 weeks the 7-day moving average increased by 94.2%, going from 134 to 260 "(figure 5).

Vaccines: supplies.

Of the doses scheduled for the first quarter of 2021, 8,597,500 doses were delivered to the Regions as of March 17 (update 6.01), just over half of those scheduled. In detail:

"Given that to meet the contractual deadlines set on March 31 – comments Cartabellotta – over 7 million doses remain to be delivered in the next two weeks, Europe must implement new tools to guarantee supplies, under penalty of continuous postponement of vaccination plans. all countries".

Vaccines: administrations.

As of March 17 (update at 6.01) 2,145,434 million people (3.6% of the population) completed the vaccination cycle with the second dose, with marked regional differences: from 2.71% in Calabria to 5.12% in Valle D'Aosta (figure 6). Unfortunately, the acceleration of mass vaccination recorded in recent weeks has suffered an inevitable setback after the precautionary and temporary blockade of the AstraZeneca vaccine, pending the final opinion of the European Medicines Agency expected today.

"Following this unfortunate episode – comments Cartabellotta – beyond the organizational times to restart, it is not possible to estimate the reduction in general adhesion to the vaccination campaign, nor the impact of individual distrust (or refusal?) With respect to the vaccine. AstraZeneca . A boomerang effect generated by a fragmented and non-linear institutional communication, the result of an impulsive decision that is more political than scientific ».

Meanwhile, compared to the protection of the most vulnerable, of the over 4.4 million over 80s, 1,258,139 (28.5%) received only the first dose of vaccine and 469,783 (10.6%) completed the vaccination cycle. with significant regional differences (figure 7). "Numbers growing – comments Gili – but still too small to observe tangible results in terms of reduction of hospitalizations and deaths in the age group most affected by Covid-19".

“Three reasonable certainties – concludes Cartabellotta – document that we are going through a very critical phase of the pandemic. First of all, the third wave started from a “plateau” causing the rapid saturation of beds in the medical and intensive care area, particularly in some Regions. Second, the trend of hospitalized and ICU patients is rapidly rising and is unlikely to peak within 3 weeks of the introduction of the new restrictive measures. Finally, the delays in vaccination supplies and the AstraZeneca case ward off the effects of the vaccination campaign. In this scenario, with a psychologically and economically exhausted population and health workers on the brink, what will be the change of pace of the Draghi government to save, at least in part, the summer season? ».

This is a machine translation from Italian language of a post published on Start Magazine at the URL https://www.startmag.it/mondo/vaccini-in-italia-forniture-e-somministrazioni-ecco-i-dati-aggiornati/ on Thu, 18 Mar 2021 08:49:37 +0000.